Observational studyThe journal of headache and pain2024

Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study.

Licia Grazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.